NEXT BIOMETRICS GROUP AS (NEXT.OL) Fundamental Analysis & Valuation

OSL:NEXT • NO0013740142

Current stock price

4.399 NOK
-0.19 (-4.16%)
Last:

This NEXT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NEXT.OL Profitability Analysis

1.1 Basic Checks

  • In the past year NEXT has reported negative net income.
  • In the past year NEXT has reported a negative cash flow from operations.
  • NEXT had negative earnings in each of the past 5 years.
  • In the past 5 years NEXT always reported negative operating cash flow.
NEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFNEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M

1.2 Ratios

  • The Return On Assets of NEXT (-172.72%) is worse than 93.62% of its industry peers.
  • NEXT has a Return On Equity of -337.92%. This is amonst the worse of the industry: NEXT underperforms 91.49% of its industry peers.
Industry RankSector Rank
ROA -172.72%
ROE -337.92%
ROIC N/A
ROA(3y)-94.36%
ROA(5y)-71.65%
ROE(3y)-159.33%
ROE(5y)-114.19%
ROIC(3y)N/A
ROIC(5y)N/A
NEXT.OL Yearly ROA, ROE, ROICNEXT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • NEXT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NEXT.OL Yearly Profit, Operating, Gross MarginsNEXT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. NEXT.OL Health Analysis

2.1 Basic Checks

  • NEXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NEXT has been increased compared to 1 year ago.
  • The number of shares outstanding for NEXT has been increased compared to 5 years ago.
  • NEXT has a worse debt/assets ratio than last year.
NEXT.OL Yearly Shares OutstandingNEXT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NEXT.OL Yearly Total Debt VS Total AssetsNEXT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • NEXT has an Altman-Z score of -8.73. This is a bad value and indicates that NEXT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of NEXT (-8.73) is worse than 89.36% of its industry peers.
  • A Debt/Equity ratio of 0.04 indicates that NEXT is not too dependend on debt financing.
  • The Debt to Equity ratio of NEXT (0.04) is better than 82.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -8.73
ROIC/WACCN/A
WACC8.3%
NEXT.OL Yearly LT Debt VS Equity VS FCFNEXT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

2.3 Liquidity

  • NEXT has a Current Ratio of 1.88. This is a normal value and indicates that NEXT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.88, NEXT is in the better half of the industry, outperforming 63.83% of the companies in the same industry.
  • A Quick Ratio of 0.78 indicates that NEXT may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.78, NEXT is doing worse than 76.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 0.78
NEXT.OL Yearly Current Assets VS Current LiabilitesNEXT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. NEXT.OL Growth Analysis

3.1 Past

  • NEXT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -74.62%.
  • The Revenue for NEXT has decreased by -85.79% in the past year. This is quite bad
  • The Revenue for NEXT have been decreasing by -25.47% on average. This is quite bad
EPS 1Y (TTM)-74.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.63%
Revenue 1Y (TTM)-85.79%
Revenue growth 3Y-34.83%
Revenue growth 5Y-25.47%
Sales Q2Q%-80.93%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEXT.OL Yearly Revenue VS EstimatesNEXT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NEXT.OL Yearly EPS VS EstimatesNEXT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

More info and screens

Find the best growth stocksShow best growing peers

0

4. NEXT.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NEXT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEXT.OL Price Earnings VS Forward Price EarningsNEXT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEXT.OL Per share dataNEXT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NEXT.OL Dividend Analysis

5.1 Amount

  • No dividends for NEXT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEXT.OL Fundamentals: All Metrics, Ratios and Statistics

NEXT BIOMETRICS GROUP AS

OSL:NEXT (4/28/2026, 3:03:04 PM)

4.399

-0.19 (-4.16%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-11
Earnings (Next)05-26
Inst Owners5.49%
Inst Owner ChangeN/A
Ins Owners7.13%
Ins Owner ChangeN/A
Market Cap52.74M
Revenue(TTM)10.17M
Net Income(TTM)-85.09M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.18
P/FCF N/A
P/OCF N/A
P/B 2.09
P/tB 2.3
EV/EBITDA N/A
EPS(TTM)-0.72
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.99
FCFYN/A
OCF(TTM)-5.8
OCFYN/A
SpS0.85
BVpS2.1
TBVpS1.92
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -172.72%
ROE -337.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-94.36%
ROA(5y)-71.65%
ROE(3y)-159.33%
ROE(5y)-114.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 46.7%
Cap/Sales 21.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 0.78
Altman-Z -8.73
F-Score1
WACC8.3%
ROIC/WACCN/A
Cap/Depr(3y)19.32%
Cap/Depr(5y)12.36%
Cap/Sales(3y)6.41%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-85.79%
Revenue growth 3Y-34.83%
Revenue growth 5Y-25.47%
Sales Q2Q%-80.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.84%
OCF growth 3YN/A
OCF growth 5YN/A

NEXT BIOMETRICS GROUP AS / NEXT.OL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NEXT BIOMETRICS GROUP AS (NEXT.OL) stock?

ChartMill assigns a fundamental rating of 1 / 10 to NEXT.OL.


Can you provide the valuation status for NEXT BIOMETRICS GROUP AS?

ChartMill assigns a valuation rating of 0 / 10 to NEXT BIOMETRICS GROUP AS (NEXT.OL). This can be considered as Overvalued.


Can you provide the profitability details for NEXT BIOMETRICS GROUP AS?

NEXT BIOMETRICS GROUP AS (NEXT.OL) has a profitability rating of 0 / 10.


What is the financial health of NEXT BIOMETRICS GROUP AS (NEXT.OL) stock?

The financial health rating of NEXT BIOMETRICS GROUP AS (NEXT.OL) is 2 / 10.